151 related articles for article (PubMed ID: 33005399)
1. Future perspectives of surgical treatment of breast cancer.
Riis M
Ann Med Surg (Lond); 2020 Nov; 59():93-95. PubMed ID: 33005399
[TBL] [Abstract][Full Text] [Related]
2. Modern surgical treatment of breast cancer.
Riis M
Ann Med Surg (Lond); 2020 Aug; 56():95-107. PubMed ID: 32637082
[TBL] [Abstract][Full Text] [Related]
3. How Can We Improve Education of Breast Surgeons Across Europe?
Kolacinska A
Chirurgia (Bucur); 2017; 112(4):365-366. PubMed ID: 28862111
[TBL] [Abstract][Full Text] [Related]
4. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
5. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
6. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
7. Surgical intensive care - current and future challenges?
Rohrig SAH; Lance MD; Faisal Malmstrom M
Qatar Med J; 2019; 2019(2):3. PubMed ID: 31976309
[TBL] [Abstract][Full Text] [Related]
8. Critical Care Network in the State of Qatar.
Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
[TBL] [Abstract][Full Text] [Related]
9. Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting.
Kühn T; Classe JM; Gentilini OD; Tinterri C; Peintinger F; de Boniface J
Breast Care (Basel); 2018 Oct; 13(5):337-341. PubMed ID: 30498418
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Therapy for HER2-positive Breast Cancer.
Wuerstlein R; Harbeck N
Rev Recent Clin Trials; 2017; 12(2):81-92. PubMed ID: 28164759
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy: updates and new perspectives.
Swain SM
Oncologist; 2010; 15 Suppl 5():8-17. PubMed ID: 21138951
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer, pregnancy, and breastfeeding.
Helewa M; Lévesque P; Provencher D; Lea RH; Rosolowich V; Shapiro HM;
J Obstet Gynaecol Can; 2002 Feb; 24(2):164-80; quiz 181-4. PubMed ID: 12196882
[TBL] [Abstract][Full Text] [Related]
14. Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer.
Ponzone R; Ruatta F; Gatti M; Castellano I; Geuna E; Amato G; Kubatzki F; Sgandurra P; Sapino A; Montemurro F
Cancer Treat Rev; 2016 Jul; 48():1-7. PubMed ID: 27262016
[TBL] [Abstract][Full Text] [Related]
15. Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE.
Popovic L; Tomasevic Z; Stamatovic L; Markovic I; Matovina-Brko G; Buta M; Golubovic A; Selakovic V; Trifunovic J; Mutrezani Z; Ivanovic N; Nedovic J; Ninkovic S; Filipovic S; Cvetanovic A; Djordjevic N; Karanikolic A; Ivkovic-Kapic T; Vicko F
J BUON; 2018; 23(2):522-532. PubMed ID: 29745102
[TBL] [Abstract][Full Text] [Related]
16. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
17. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century.
Fisher B
Eur J Cancer; 1999 Dec; 35(14):1963-73. PubMed ID: 10711239
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant therapy for treatment of breast cancer: the way forward, or simply a convenient option for patients?
Chatterjee A; Erban JK
Gland Surg; 2017 Feb; 6(1):119-124. PubMed ID: 28210563
[TBL] [Abstract][Full Text] [Related]
19. Current and future role of neoadjuvant therapy for breast cancer.
Untch M; Konecny GE; Paepke S; von Minckwitz G
Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement.
Colomer R; Saura C; Sánchez-Rovira P; Pascual T; Rubio IT; Burgués O; Marcos L; Rodríguez CA; Martín M; Lluch A
Oncologist; 2019 May; 24(5):603-611. PubMed ID: 30710068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
